The DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
A Comprehensive Review About SARS-CoV-2
Open accessAbstract
The coronavirus disease (COVID-19) was first identified in China, December 2019. Since then, it has spread the length and breadth of the world at an unprecedented, alarming rate. Severe acute respiratory syndrome coronavirus (SARS-CoV)-2, which causes COVID-19, has much in common with its closest homologs, SARS-CoV and Middle East respiratory syndrome-CoV. The virus-host interaction of SARS-CoV-2 uses the same receptor, ACE2, which is similar to that of SARS-CoV, which spreads through the respiratory tract. Patients with COVID-19 report symptoms including mild-to-severe fever, cough and fatigue; very few patients report gastrointestinal infections. There are no specific antiviral strategies. A few strong medications are under investigation, so we have to focus on proposals which ought to be taken to forestall this infection in a living host.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The fusion of two membranes is the crucial step before the virus enters the host cell [11, 12].”
From Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe (2022) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Gorbalenya, A. E., Baker, S. C., Baric, R. S., de Groot, R. J., Drosten, C., Gulyaeva, A. A., Haagmans, B. L., Lauber, C., Leontovich, A. M., Neuman, B. W., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0695-z · Cited by 8,745
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein
Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hú, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,994
Research works printed but not linked: 4
- 10.1016/j.cell.2020.02.058 · DOI · Paper page
- 10.1101/2020.03.19.20039107v1 · DOI
- Gilead Sciences Statement on the Company’s Ongoing Response to the 2019 Novel Coronavirus (2019-nCoV). www.gilead.com/news-and-press/company-statements/gilead-sciences-statement-on-the-company-ongoing-response-to-the-2019-new-coronavirus
- Liu W , LiH. COVID-19: attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism 1 introduction. ChemRxiv11938173 (2020).
Cited by
Sorted by citations
Items 101–120 of 120
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v26
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v28
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v24
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v18
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v17
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v29
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv-2021-l393t-v34
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v22
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v27
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v23
Datta, S. (2021) · doi:10.33774/chemrxiv-2021-l393t-v34
A Year of COVID-19 Outbreak in Indonesia #2: Variant Development Based on Spike (S) Mutations
Andreanto, N. G., Novitasari, D., Pangesti, D. W., Khusufi, R. L., Sabatia, A., Oktafian, I. N., Sa’adah, N. A. M., Krisdayana, R., Iswara, S. K. H., & Listyorini, D. I. (2022) · Advances in biological sciences research/Advances in Biological Sciences Research · doi:10.2991/absr.k.220406.020
Villasana, K., Perdomo, B., Dugarte, L., Torres, G., & Pujol, J. M. (2022) · Journal of Human Virology & Retrovirology · doi:10.15406/jhvrv.2022.09.00250
Oral Findings Observed in COVID-19: Literature Review
Özden, F. O., & Karaman, E. (2023) · Yeditepe Dental Journal · doi:10.5505/yeditepe.2023.33716
Borderline SARS-CoV-2 patients: the trace behind
Mohar, B., Štefančić, E., Antić, D. R., Kezele, T. G., Abram, M., & Bubonja‐Šonje, M. (2023) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2023.2198641
Shafiq, A., Khalid, U., Rehman, U. A., Almuqri, E. A., Muddassir, M., Ahmad, S., Khan, M. I., Khan, A., & Wei, D. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2220053
Abutbul, A., Mumblat, Y., Porat, Y., Friedman, N., Atari, N., Sharabi, S., Nama, A., Mugahed, W., Kessler, A., Kolben, Y., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1296558
Moreira, A. G., & Arditi, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-79525-8.00040-8
Primer-probe set test for N1, N2, and RdRp genes from SARS-CoV-2 detection using multiplex RT-qPCR
Ikhsan, M., Nurhasanah, A., Pambudi, S., Sulfiati, A., Widayanti, T., Karimah, N., & Lestari, R. (2024) · AIP conference proceedings · doi:10.1063/5.0214494
Urogenital manifestations of SARS-CoV-2, MPXV and Zika virus: A comprehensive review
Li, Y., Fan, G., & He, H. (2025) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2025.101399
Metadata
- Authors
- Haque, S. M., Ashwaq, O., Sarief, A., & Azad John Mohamed, A. K.
- Affiliations
- Jubail Industrial College (SA)
- Department of Chemical & Process Engineering Technology Jubail Industrial College P. O. Box 10099 Jubail Industrial City 31961 Saudi Arabia
- Corresponding author
- Haque, SK Manirul
- Venue
- Future Virology
- Publisher
- Informa UK Limited
- Published
- 2020-09
- Volume
- 15
- Issue
- 9
- Pages
- 625-648
- ISSN
- 1746-0794 (ISSN-L)
- 1746-0808
- PMC
- PMC7664148
- OpenAlex
- W3096912664
- Cited by
- 121
- References
- 208
- Citations by year
- 2025: 6 · 2024: 10 · 2023: 15 · 2022: 25 · 2021: 62 · 2020: 2
- FWCI
- 1.23
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-07-08)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Future Virology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
- Keywords
- SARS-CoV-2, COVID-19 pandemic, SARS-CoV, MERS-CoV, ACE2 receptor, host-virus interaction, respiratory transmission, clinical symptoms, antiviral strategies, prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
